As legal psychedelic therapy emerges, ethicists urge for more comprehensive frameworks to address sexual abuse
With a checkered history of misconduct, how will psychedelic-assisted therapists be held accountable in the emerging legal field?
Chicago could become largest city to Decriminalize Entheogenic Plants
Chicago’s Committee on Health and Human Relations unanimously passed (50-0) a resolution October 16 to decriminalize entheogenic plants and fungi.
Third Wave staff quits, writes open letter, over work environment created by founder Paul Austin
Eight staff have quit The Third Wave and issued an open statement.
MDMA Expanded Access is almost here. What’s it all about?
The Multidisciplinary Association for Psychedelic Studies (MAPS) submitted their MDMA PTSD expanded access protocol to the FDA on January 14, 2019.
Will MDMA-assisted psychotherapy be covered by health insurance?
Until MDMA-assisted psychotherapy is proven without a doubt to reduce long-term costs, many insurance companies do not have an incentive to cover it.
How will MDMA be rescheduled in the future? You may be disappointed
What does MDMA rescheduling mean for the recreational user? If you are under the impression that MDMA is on its way to being rescheduled, across the board, you may be disappointed.
The Future of MDMA: Phase 3 and Beyond
What does the future hold for MDMA? We explore MAPS' ongoing FDA phase 3 clinical trials, rescheduling, health insurance, and expanded access.
The Bunk Police is looking to destroy dishonesty in the drug market
If there are other harm-reduction organizations, such as DanceSafe, that are able to distribute test kits, then we won’t attend that event....the ones that refuse DanceSafe, we come in and do it anyways.
Intentionally-diverse MDMA research at University of Connecticut Cut Short
The research team at UConn studying MDMA-assisted psychotherapy for PTSD is now defunct.
psychedelic.support creates a network for psychedelic therapists
psychedelic.support could soon become a useful asset to anyone interested in the professional world of psychedelic-related therapy.
